Anthony S. Chilton
Plus aucun poste en cours
Historique de carrière de Anthony S. Chilton
Anciens postes connus de Anthony S. Chilton
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INOTIV, INC. | Directeur/Membre du Conseil | 14/02/2011 | 02/03/2012 |
| Corporate Officer/Principal | 01/12/2008 | 28/01/2010 | |
| President | 28/01/2010 | 05/07/2012 | |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01/01/1998 | - |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Corporate Officer/Principal | 22/03/2010 | - |
Formation de Anthony S. Chilton
| University of East Anglia | Undergraduate Degree |
| University of Hertfordshire | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Royaume-Uni | 3 |
| Espagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| President | 1 |
Sectorielle
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INOTIV, INC. | Commercial Services |
| CARDINAL HEALTH, INC. | Distribution Services |
| Entreprise privées | 1 |
|---|---|
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain. | Health Technology |
- Bourse
- Insiders
- Anthony S. Chilton
- Expérience
